Adamo Annalisa, Delfino Pietro, Gatti Alessandro, Bonato Alice, Takam Kamga Paul, Bazzoni Riccardo, Ugel Stefano, Mercuri Angela, Caligola Simone, Krampera Mauro
Stem Cell Research Laboratory, Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
Department of Medicine, Section of Immunology, University of Verona, Verona, Italy.
Front Cell Dev Biol. 2020 Nov 5;8:584232. doi: 10.3389/fcell.2020.584232. eCollection 2020.
In this study, we compared the overall gene and pathway expression profiles of HS-5 and HS-27A stromal cell lines with those of primary bone marrow MSCs to verify if they can be considered a reliable alternative tool for evaluating the contribution of MSCs in tumor development and immunomodulation. Indeed, due to their easier manipulation as compared to primary MSC cultures, several published studies took advantage of stromal cell lines to assess the biological mechanisms mediated by stromal cells in influencing tumor biology and immune responses. However, the process carried out to obtain immortalized cell lines could profoundly alter gene expression profile, and consequently their biological characteristics, leading to debatable results. Here, we evaluated the still undisclosed similarities and differences between HS-5, HS-27A cell lines and primary bone marrow MSCs in the context of tumor development and immunomodulation. Furthermore, we assessed by standardized immunological assays the capability of the cell lines to reproduce the general mechanisms of MSC immunoregulation. We found that only HS-5 cell line could be suitable to reproduce not only the MSC capacity to influence tumor biology, but also to evaluate the molecular mechanisms underlying tumor immune escape mediated by stroma cells. However, HS-5 pre-treatment with inflammatory cytokines, that normally enhances the immunosuppressive activity of primary MSCs, did not reproduce the same MSCs behavior, highlighting the necessity to accurately set up assays when HS-5 cell line is used instead of its primary counterpart.
在本研究中,我们将HS-5和HS-27A基质细胞系的整体基因和通路表达谱与原代骨髓间充质干细胞(MSC)的表达谱进行了比较,以验证它们是否可被视为评估MSC在肿瘤发展和免疫调节中作用的可靠替代工具。事实上,与原代MSC培养物相比,由于基质细胞系更容易操作,一些已发表的研究利用基质细胞系来评估基质细胞介导的影响肿瘤生物学和免疫反应的生物学机制。然而,获得永生化细胞系的过程可能会深刻改变基因表达谱,进而改变其生物学特性,导致结果存在争议。在此,我们评估了HS-5、HS-27A细胞系与原代骨髓MSC在肿瘤发展和免疫调节方面尚未揭示的异同。此外,我们通过标准化免疫分析评估了细胞系再现MSC免疫调节一般机制的能力。我们发现,只有HS-5细胞系不仅能够再现MSC影响肿瘤生物学的能力,还能评估基质细胞介导的肿瘤免疫逃逸的分子机制。然而,用炎症细胞因子对HS-5进行预处理(这通常会增强原代MSC的免疫抑制活性)并不能再现相同的MSC行为,这突出表明当使用HS-5细胞系替代原代细胞时,需要准确建立分析方法。